GSK
@gsk.bsky.social
42 followers 63 following 18 posts
We are uniting science, technology and talent to get ahead of disease together.
Posts Media Videos Starter Packs
“It’s hard to explain the pain of a UTI to people who’ve never had one.”

🔗 Read LeAnn’s story and why she thinks personalised care is so important: gsk.to/4hkD8aO

#IDWeek2025
Modern medicine has revolutionised the way we live but the challenges to our health are evolving. Find out why preventing disease is the best investment not just for people but also for the world’s health systems, societies and economies 👇

#IDWeek2025
'Prevention is the best medicine to stop disease before it starts' | GSK
Investing in prevention delivers better health outcomes for patients, is cost-effective, and boosts the economy
gsk.to
Understanding the challenges faced by those living with gynaecologic cancers is key to driving change.

Visit us at #ESMO25 to learn more about our Your Cancer Is Our Challenge survey and how we’re working to amplify patient voices and improve care.

🔗 Learn more: bit.ly/4h9h2YB
Globally, one in five people will be diagnosed with cancer in their lifetime. We’re working to change outcomes for patients facing that reality.

By advancing innovative oncology research, we’re aiming to redefine what’s possible in cancer care.

➡️ Find us at #ESMO25 this week to learn more.
Evolving health threats demand focus on prevention. At the #WorldHealthSummit, we discussed the need to work together to help preventative interventions reach people who need them. Prioritising prevention can transform lives, protect global health & boost economies: gsk.to/3W4Etc2
Great discussion with @statnews.com and @matthewherper.bsky.social at the 2025 #StatSummit. Emma highlighted our strong investment in the US, focus on preventative healthcare, and how AI is reshaping our business.
At the @worldhealthsummit.bsky.social, we came together with @savechildrenuk.bsky.social to explore the role of partnerships in tackling evolving global health challenges.

Collaboration is key for innovation and access to healthcare. Learn more in our impact report: gsk.to/474wYXt
#News for #Investors and #Media: Data presented at #EACS2025 by our specialist HIV company, ViiV Healthcare, offer a deeper understanding of therapy options & could help individuals & their healthcare providers make more fully informed choices about their HIV care. Find out more: gsk.to/4qacmpF
Inspiring to see our CEO Emma Walmsley at the Fortune Most Powerful Women Summit in D.C.

She shared her vision for the future of healthcare, touching on cancer treatment discoveries & AI's role, and reflected on her nine years leading GSK's transformation.

#FortuneMPW
Technology transfers are one of the tools available to support access to new innovations in vaccines and medicines, including antibiotics. At the @worldhealthsummit.bsky.social, we co-hosted a panel discussion to highlight the opportunities that tech transfer brings, but also the complexities.
We believe in the power of vaccines to protect billions.
We believe HIV has a past but not a future.
We believe prevention is the best medicine.
We believe that getting ahead of disease requires understanding its root cause.
We believe outsmarting cancer demands focus.
We believe beating respiratory disease demands breathtaking innovation.
Give us a follow to stay in the loop and join the conversation! #GSK #HelloBluesky
We're here to share our journey of uniting science, tech, and talent to help get ahead of disease, together. Expect updates on our ongoing research, developments in vaccines and medicines, and how we're making a positive impact on global health.

We're looking forward to connecting with you.